ClinicalTrials.Veeva
Menu

Find clinical trials for Multiple Myeloma in Cincinnati, OH

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Plasma Cell Cancer
Recurrence
Cancer
Hematologic Cancer
Lymphoma
Smoldering Multiple Myeloma
Leukemia

Multiple Myeloma trials near Cincinnati, OH, USA:

Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma

This is a phase II study to evaluate the outpatient administration of Teclistamab or Talquetamab in Multiple Myeloma patients...

Enrolling
Multiple Myeloma
Drug: Teclistamab
Drug: Talquetamab

Phase 2

SCRI Development Innovations

Cincinnati, Ohio, United States of America and 16 other locations

This is a Phase I dose-finding study of FT576 as monotherapy and in combination with the monoclonal antibody daratumumab in multiple myeloma...

Active, not recruiting
Multiple Myeloma
Myeloma
Drug: Cyclophosphamide
Drug: Bendamustine

Phase 1

Fate Therapeutics
Fate Therapeutics

Cincinnati, Ohio, United States of America and 13 other locations

This is an open-label, multi-site, Phase II randomized trial with response-adaptive design for newly diagnosed multiple myeloma (ND...

Enrolling
Multiple Myeloma, Newly Diagnosed
Multiple Myeloma (MM)
Drug: Elranatamab
Drug: Lenalidomide

Phase 2

SCRI Development Innovations

Cincinnati, Ohio, United States of America and 5 other locations

of care therapy (SOCT) in participants with relapsed/refractory multiple myeloma who have received 1 to 3 prior lines of therapy, i...

Enrolling
Multiple Myeloma
Drug: Fludarabine
Drug: Cyclophosphamide

Phase 3

Gilead Sciences
Gilead Sciences

Cincinnati, Ohio, United States and 109 other locations

Multiple Myeloma (MM) is a cancer of the blood's plasma cells ( blood cell). The cancer is typically found in the bones and bone ma...

Enrolling
Multiple Myeloma
Drug: ABBV-383

Phase 1

AbbVie
AbbVie

Cincinnati, Ohio, United States and 40 other locations

of this study is to evaluate the effectiveness and safety of Arlocabtagene Autoleucel (BMS-986393) in participants with relapsed or refractory multiple...

Enrolling
Multiple Myeloma
Biological: Arlocabtagene Autoleucel

Phase 2

Juno Therapeutics

Cincinnati, Ohio, United States of America and 51 other locations

of CB-011, and to assess the effectiveness of CB-011 in treating multiple myeloma that has come back (relapsed) or that is no longe...

Enrolling
Relapsed/Refractory Multiple Myeloma
Biological: CB-011

Phase 1

Caribou Biosciences

Cincinnati, Ohio, United States of America and 15 other locations

Multiple myeloma (MM) is a cancer of the blood's plasma cells. The cancer is typically found in the bones and bone marrow (the spon...

Enrolling
Multiple Myeloma
Drug: Dexamethasone
Drug: Lenalidomide

Phase 1, Phase 2

AbbVie
AbbVie

Cincinnati, Ohio, United States and 18 other locations

This open-label, randomized study for evaluating the efficacy and safety of single agent belantamab mafodotin when compared to pom/dex in participant...

Active, not recruiting
Multiple Myeloma
Drug: Belantamab mafodotin
Drug: Pom/dex (Pomalidomide plus low dose Dexamethasone)

Phase 3

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

Cincinnati, Ohio, United States and 135 other locations

Multiple myeloma (MM) is a cancer of the blood's plasma cells. The cancer is typically found in the bones and bone marrow (the spon...

Enrolling
Multiple Myeloma
Drug: Carfilzomib
Drug: Etentamig

Phase 3

AbbVie
AbbVie

Cincinnati, Ohio, United States and 163 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems